Addressing brain metabolic connectivity in treatment-resistant schizophrenia: a novel graph theory-driven application of 18F-FDG-PET with antipsychotic dose correction
2024

Brain Connectivity in Treatment-Resistant Schizophrenia

Sample size: 70 publication 10 minutes Evidence: moderate

Author Information

Author(s): De Simone Giuseppe, Iasevoli Felice, Barone Annarita, Gaudieri Valeria, Cuocolo Alberto, Ciccarelli Mariateresa, Pappatà Sabina, de Bartolomeis Andrea

Primary Institution: University of Naples “Federico II”

Hypothesis

This study aims to explore differential patterns of glucose metabolism between patients with treatment-resistant schizophrenia and controls using a graph theory-based approach.

Conclusion

The study found significant alterations in brain connectivity in treatment-resistant schizophrenia patients compared to controls, particularly in the frontal lobe and Default Mode Network.

Supporting Evidence

  • Global reduced connectivity was detected in the treatment-resistant and treatment-responsive groups compared to controls.
  • Alterations in the anterior cingulate and frontal gyri emerged after adjusting for antipsychotic doses.
  • The machine-learning approach demonstrated an accuracy ranging from 0.72 to 0.8 in detecting treatment-resistant schizophrenia.

Takeaway

Researchers looked at how the brains of people with treatment-resistant schizophrenia work differently compared to those who respond to treatment, finding important differences in brain connectivity.

Methodology

The study used 18F-FDG-PET scans to analyze brain glucose metabolism in 70 subjects, including treatment-resistant and treatment-responsive schizophrenia patients and healthy controls, employing graph theory and machine learning for analysis.

Potential Biases

The unequal sample sizes between groups may introduce bias.

Limitations

The relatively small sample size and the potential confounding effects of antipsychotic medication on brain connectivity.

Participant Demographics

The study included 70 participants: 26 with treatment-resistant schizophrenia, 28 treatment-responsive patients, and 16 healthy controls.

Statistical Information

P-Value

0.001

Confidence Interval

95% C.I. = 0.74, 0.96

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/s41537-024-00535-4

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication